Target
Serine/threonine-protein kinase B-raf [416-766,V600E]
Ligand
BDBM313396
Substrate
n/a
Meas. Tech.
In Vitro Raf Activity Determination
IC50
613±n/a nM
Citation
 Aversa, RJBurger, MTDillon, MPDineen, Jr., TALou, YNishiguchi, GARamurthy, SRico, ACRauniyar, VSendzik, MSubramanian, SSetti, LQTaft, BRTanner, HRWan, L Compounds and compositions as RAF kinase inhibitors US Patent  US10167279 Publication Date 1/1/2019 
Target
Name:
Serine/threonine-protein kinase B-raf [416-766,V600E]
Synonyms:
B-Raf (V600E) | BRAF | BRAF1 | BRAF_HUMAN | RAFB1
Type:
n/a
Mol. Mass.:
39690.71
Organism:
Homo sapiens (Human)
Description:
PV3849, from Invitrogen
Residue:
351
Sequence:
LQKSPGPQRERKSSSSSEDRNRMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPKIHRSASEPSLNRAGFQTEDFSLYACASPKTPIQAGGYGAFPVH
  
Inhibitor
Name:
BDBM313396
Synonyms:
N-(6'-ethoxy-2-methyl- 5'-(3-methyloxetan-3- yl)-[3,3'-bipyridin]-5- yl)-2- (trifluoromethyl)isonicotin- amide | US10167279, Example 63
Type:
Small organic molecule
Emp. Form.:
C24H23F3N4O3
Mol. Mass.:
472.4596
SMILES:
CCOc1ncc(cc1C1(C)COC1)-c1cc(NC(=O)c2ccnc(c2)C(F)(F)F)cnc1C
Structure:
Search PDB for entries with ligand similarity: